Aberrant expression of FoxP3 in a human T cell line possessing regulatory T cell‑like function and exposed continuously to asbestos fibers

Maeda,Megumi; Matsuzaki,Hidenori; Yamamoto,Shoko; Lee,Suni; Kumagai‑Takei,Naoko; Yoshitome,Kei; Min,Yu; Sada,Nagisa; Nishimura,Yasumitsu; Otsuki,Takemi

doi:10.3892/or.2018.6481

Aberrant expression of FoxP3 in a human T cell line possessing regulatory T cell‑like function and exposed continuously to asbestos fibers

Authors:
- Megumi Maeda
- Hidenori Matsuzaki
- Shoko Yamamoto
- Suni Lee
- Naoko Kumagai‑Takei
- Kei Yoshitome
- Yu Min
- Nagisa Sada
- Yasumitsu Nishimura
- Takemi Otsuki
View Affiliations

Affiliations: Department of Biofunctional Chemistry, Division of Bioscience, Okayama University Graduate School of Natural Science and Technology, Kita‑Ku, Okayama 700‑8530, Japan, Department of Hygiene, Kawasaki Medical School, Kurashiki, Okayama 701‑0192, Japan
Published online on: June 7, 2018 https://doi.org/10.3892/or.2018.6481
Pages: 748-758

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Prompted by the known carcinogenic activity of asbestos, our investigations revealed that asbestos causes a reduction in antitumor immunity. One mechanism involves the enhancement of regulatory T (Treg) cell function and volume assayed using MT‑2 original cells (Org), an HTLV‑1 immortalized human T cell line which possesses Treg‑like function. Continuous and relatively low‑dose exposure of MT‑2 to asbestos fibers yielded sublines resistant to asbestos‑induced apoptosis and enhanced Treg function via cell‑cell contact mechanisms and increased the production of soluble factors such as interleukin (IL)‑10 and transforming growth factor (TGF)‑β. Additionally, cell cycle progression was accelerated in these sublines. Subsequently, the status of the Treg‑specific transcription factor FoxP3 was examined. Unexpectedly, FoxP3 mRNA levels decreased in the sublines, although significant changes in protein expression were absent. Methylation analysis of CpG sites located in the promoter region of FoxP3 in original MT‑2 cells and sublines showed almost complete methylation in Org and slight hypomethylation in the sublines. Although treatment with the demethylating agent 5‑aza‑deoxycytidine tended to upregulate FoxP3 expression, the methylation status did not match the mRNA expression and enhanced function. Additionally, the expression of other transcription factors related to Treg did not differ between Org and subline CB1. Collectively, aberrant expression and methylation patterns of FoxP3 were detected in human T cells continuously exposed to asbestos, although cell function was enhanced by asbestos exposure. Future analyses to identify factors responsible for Treg functional enhancements induced by asbestos, such as the investigation of surface molecules, are needed for the development of strategies to prevent the occurrence of asbestos‑induced cancers.

View Figures

View References

1	Attanoos R: Lung cancer associated with asbestos exposure. Asbestos and Its Diseases. Craighead JE and Gibbs AR: Oxford University Press; New York: pp. 172–189. 2008, View Article : Google Scholar
2	Hammar SP: Asbestos and mesothelioma. Sebstos; Risk Assessment, Epidemiology, and Health Effects. Dodson RF and Hammar SP: 2nd. CRC Press; Boca Raton, FL: pp. 307–418. 2011, View Article : Google Scholar
3	Asbestos and Mesothelioma (Current Cancer Research). Testa JR: Springer International Publishing; Gewerbestrasse, Switzerland: 2017
4	International Agency for Research on Cancer. A review of human carcinogens: Arsenic, metals, fibres, and dusts (iarc monographs on the evaluation of the carcinogenic risks to humans). WHO Press; Lyon, France: 2012
5	Shukla A, Gulumian M, Hei TK, Kamp D, Rahman Q and Mossman BT: Multiple roles of oxidants in the pathogenesis of asbestos-induced diseases. Free Radic Biol Med. 34:1117–1129. 2003. View Article : Google Scholar : PubMed/NCBI
6	Upadhyay D and Kamp DW: Asbestos-induced pulmonary toxicity: Role of DNA damage and apoptosis. Exp Biol Med. 228:650–659. 2003. View Article : Google Scholar
7	Liu X and Chen Z: The pathophysiological role of mitochondrial oxidative stress in lung diseases. J Transl Med. 15:2072017. View Article : Google Scholar : PubMed/NCBI
8	Simeonova PP and Luster MI: Iron and reactive oxygen species in the asbestos-induced tumor necrosis factor-alpha response from alveolar macrophages. Am J Respir Cell Mol Biol. 12:676–683. 1995. View Article : Google Scholar : PubMed/NCBI
9	Boyles MS, Young L, Brown DM, MacCalman L, Cowie H, Moisala A, Smail F, Smith PJ, Proudfoot L, Windle AH, et al: Multi-walled carbon nanotube induced frustrated phagocytosis, cytotoxicity and pro-inflammatory conditions in macrophages are length dependent and greater than that of asbestos. Toxicol In Vitro. 29:1513–1528. 2015. View Article : Google Scholar : PubMed/NCBI
10	Toyokuni S: Mechanisms of asbestos-induced carcinogenesis. Nagoya J Med Sci. 71:1–10. 2009.PubMed/NCBI
11	Chew SH and Toyokuni S: Malignant mesothelioma as an oxidative stress-induced cancer: An update. Free Radic Biol Med. 86:166–178. 2015. View Article : Google Scholar : PubMed/NCBI
12	Otsuki T, Maeda M, Murakami S, Hayashi H, Miura Y, Kusaka M, Nakano T, Fukuoka K, Kishimoto T, Hyodoh F, et al: Immunological effects of silica and asbestos. Cell Mol Immunol. 4:261–268. 2007.PubMed/NCBI
13	Kumagai-Takei N, Maeda M, Chen Y, Matsuzaki H, Lee S, Nishimura Y, Hiratsuka J and Otsuki T: Asbestos induces reduction of tumor immunity. Clin Dev Immunol. 2011:4814392011. View Article : Google Scholar : PubMed/NCBI
14	Otsuki T, Matsuzaki H, Lee S, Kumagai-Takei N, Yamamoto S, Hatayama T, Yoshitome K and Nishimura Y: Environmental factors and human health: Fibrous and particulate substance-induced immunological disorders and construction of a health-promoting living environment. Environ Health Prev Med. 21:71–81. 2016. View Article : Google Scholar : PubMed/NCBI
15	Nishimura Y, Miura Y, Maeda M, Kumagai N, Murakami S, Hayashi H, Fukuoka K, Nakano T and Otsuki T: Impairment in cytotoxicity and expression of NK cell-activating receptors on human NK cells following exposure to asbestos fibers. Int J Immunopathol Pharmacol. 22:579–590. 2009. View Article : Google Scholar : PubMed/NCBI
16	Nishimura Y, Maeda M, Kumagai N, Hayashi H, Miura Y and Otsuki T: Decrease in phosphorylation of ERK following decreased expression of NK cell-activating receptors in human NK cell line exposed to asbestos. Int J Immunopathol Pharmacol. 22:879–888. 2009. View Article : Google Scholar : PubMed/NCBI
17	Kumagai-Takei N, Nishimura Y, Maeda M, Hayashi H, Matsuzaki H, Lee S, Hiratsuka J and Otsuki T: Effect of asbestos exposure on differentiation of cytotoxic T lymphocytes in mixed lymphocyte reaction of human peripheral blood mononuclear cells. Am J Respir Cell Mol Biol. 49:28–36. 2013. View Article : Google Scholar : PubMed/NCBI
18	Maeda M, Nishimura Y, Hayashi H, Kumagai N, Chen Y, Murakami S, Miura Y, Hiratsuka J, Kishimoto T and Otsuki T: Reduction of CXC chemokine receptor 3 in an in vitro model of continuous exposure to asbestos in a human T-cell line, MT-2. Am J Respir Cell Mol Biol. 45:470–479. 2011. View Article : Google Scholar : PubMed/NCBI
19	Maeda M, Nishimura Y, Hayashi H, Kumagai N, Chen Y, Murakami S, Miura Y, Hiratsuka J, Kishimoto T and Otsuki T: Decreased CXCR3 expression in CD4⁺ T cells exposed to asbestos or derived from asbestos-exposed patients. Am J Respir Cell Mol Biol. 45:795–803. 2011. View Article : Google Scholar : PubMed/NCBI
20	Chen X, Du Y, Lin X, Qian Y, Zhou T and Huang Z: CD4 + CD25 + regulatory T cells in tumor immunity. Int Immunopharmacol. 34:244–249. 2016. View Article : Google Scholar : PubMed/NCBI
21	Szylberg Ł, Karbownik D and Marszałek A: The role of foxP3 in human cancers. Anticancer Res. 36:3789–3794. 2016.PubMed/NCBI
22	Tanaka A and Sakaguchi S: Regulatory T cells in cancer immunotherapy. Cell Res. 27:109–118. 2017. View Article : Google Scholar : PubMed/NCBI
23	Hamano R, Wu X, Wang Y, Oppenheim JJ and Chen X: Characterization of MT-2 cells as a human regulatory T cell-like cell line. Cell Mol Immunol. 12:780–782. 2015. View Article : Google Scholar : PubMed/NCBI
24	Chen S1, Ishii N, Ine S, Ikeda S, Fujimura T, Ndhlovu LC, Soroosh P, Tada K, Harigae H, Kameoka J, et al: Regulatory T cell-like activity of Foxp3⁺ adult T cell leukemia cells. Int Immunol. 18:269–277. 2006. View Article : Google Scholar : PubMed/NCBI
25	Hyodoh F, Takata-Tomokuni A, Miura Y, Sakaguchi H, Hatayama T, Hatada S, Katsuyama H, Matsuo Y and Otsuki T: Inhibitory effects of anti-oxidants on apoptosis of a human polyclonal T-cell line, MT-2, induced by an asbestos, chrysotile-A. Scand J Immunol. 61:442–448. 2005. View Article : Google Scholar : PubMed/NCBI
26	Miura Y, Nishimura Y, Katsuyama H, Maeda M, Hayashi H, Dong M, Hyodoh F, Tomita M, Matsuo Y, Uesaka A, et al: Involvement of IL-10 and Bcl-2 in resistance against an asbestos-induced apoptosis of T cells. Apoptosis. 11:1825–1835. 2006. View Article : Google Scholar : PubMed/NCBI
27	Maeda M, Yamamoto S, Chen Y, Kumagai-Takei N, Hayashi H, Matsuzaki H, Lee S, Hatayama T, Miyahara N, Katoh M, et al: Resistance to asbestos-induced apoptosis with continuous exposure to crocidolite on a human T cell. Sci Total Environ. 429:174–182. 2012. View Article : Google Scholar : PubMed/NCBI
28	Maeda M, Chen Y, Hayashi H, Kumagai-Takei N, Matsuzaki H, Lee S, Nishimura Y and Otsuki T: Chronic exposure to asbestos enhances TGF-β1 production in the human adult T cell leukemia virus-immortalized T cell line MT-2. Int J Oncol. 45:2522–2532. 2014. View Article : Google Scholar : PubMed/NCBI
29	Ying C, Maeda M, Nishimura Y, Kumagai-Takei N, Hayashi H, Matsuzaki H, Lee S, Yoshitome K, Yamamoto S, Hatayama T and Otsuki T: Enhancement of regulatory T cell-like suppressive function in MT-2 by long-term and low-dose exposure to asbestos. Toxicology. 338:86–94. 2015. View Article : Google Scholar : PubMed/NCBI
30	Matsuzaki H, Lee S, Maeda M, Kumagai-Takei N, Nishimura Y and Otsuki T: FoxO1 regulates apoptosis induced by asbestos in the MT-2 human T-cell line. J Immunotoxicol. 13:620–627. 2016. View Article : Google Scholar : PubMed/NCBI
31	Lee S, Matsuzaki H, Maeda M, Yamamoto S, Kumagai-Takei N, Hatayama T, Ikeda M, Yoshitome K, Nishimura Y and Otsuki T: Accelerated cell cycle progression of human regulatory T cell-like cell line caused by continuous exposure to asbestos fibers. Int J Oncol. 50:66–74. 2017. View Article : Google Scholar : PubMed/NCBI
32	Maeda M, Yamamoto S, Hatayama T, Matsuzaki H, Lee S, Kumagai-Takei N, Yoshitome K, Nishimura Y, Kimura Y and Otsuki T: T cell alteration caused by exposure to asbestos. Biological Effects of Fibrous and Particulate Substances. Otsuki T, Holian A and Yoshioka Y: Springer; Japan, Tokyo: pp. 195–210. 2015
33	Kohyama N, Shinohara Y and Suzuki Y: Mineral phases and some reexamined characteristics of the international union against cancer standard asbestos samples. Am J Ind Med. 30:515–528. 1996. View Article : Google Scholar : PubMed/NCBI
34	Boden E, Tang Q, Bour-Jordan H and Bluestone JA: The role of CD28 and CTLA4 in the function and homeostasis of CD4+CD25+ regulatory T cells. Novartis Found Symp. 252:55–63. 2003.PubMed/NCBI
35	Ko K, Yamazaki S, Nakamura K, Nishioka T, Hirota K, Yamaguchi T, Shimizu J, Nomura T, Chiba T and Sakaguchi S: Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3⁺CD25⁺CD4⁺ regulatory T cells. J Exp Med. 202:885–891. 2005. View Article : Google Scholar : PubMed/NCBI
36	Thornton AM, Korty PE, Tran DQ, Wohlfert EA, Murray PE, Belkaid Y and Shevach EM: Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3⁺ T regulatory cells. J Immunol. 184:3433–3441. 2010. View Article : Google Scholar : PubMed/NCBI
37	Grzanka J, Leveson-Gower D, Golab K, Wang XJ, Marek-Trzonkowska N, Krzystyniak A, Wardowska A, Mills JM, Trzonkowski P and Witkowski P: FoxP3, Helios, and SATB1: Roles and relationships in regulatory T cells. Int Immunopharmacol. 16:343–347. 2013. View Article : Google Scholar : PubMed/NCBI
38	Ono M, Yaguchi H, Ohkura N, Kitabayashi I, Nagamura Y, Nomura T, Miyachi Y, Tsukada T and Sakaguchi S: Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature. 446:685–689. 2007. View Article : Google Scholar : PubMed/NCBI
39	Maeda M, Chen Y, Lee S, Kumagai-Takei N, Yoshitome K, Matsuzaki H, Yamamoto S, Hatayama T, Ikeda M, Nishimura Y and Otsuki T: Induction of IL-17 production from human peripheral blood CD4⁺ cells by asbestos exposure. Int J Oncol. 50:2024–2032. 2017. View Article : Google Scholar : PubMed/NCBI
40	Kumagai-Takei N, Nishimura Y, Maeda M, Hayashi H, Matsuzaki H, Lee S, Kishimoto T, Fukuoka K, Nakano T and Otsuki T: Functional properties of CD8⁺ lymphocytes in patients with pleural plaque and malignant mesothelioma. J Immunol Res. 2014:6701402014. View Article : Google Scholar : PubMed/NCBI
41	Maeda M, Chen Y, Kumagai-Takei N, Hayashi H, Matsuzaki H, Lee S, Hiratsuka J, Nishimura Y, Kimura Y and Otsuki T: Alteration of cytoskeletal molecules in a human T cell line caused by continuous exposure to chrysotile asbestos. Immunobiology. 218:1184–1191. 2013. View Article : Google Scholar : PubMed/NCBI
42	Wang L, Tao R and Hancock WW: Using histone deacetylase inhibitors to enhance Foxp3⁺ regulatory T-cell function and induce allograft tolerance. Immunol Cell Biol. 87:195–202. 2009. View Article : Google Scholar : PubMed/NCBI
43	Bennett MK and Kirk CJ: Development of proteasome inhibitors in oncology and autoimmune diseases. Curr Opin Drug Discov Devel. 11:616–625. 2008.PubMed/NCBI